المؤلفون: Kondoh Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, 160 Nishioiwake-cho, Seto, Aichi, 489-8642, Japan. Electronic address: yshr.kondoh@gmail.com., Ito T; Nippon Boehringer Ingelheim Co., Ltd., 2-1-1 Osaki, Shinagawa-ku, Tokyo, 141-6017, Japan. Electronic address: tomohiro.ito@boehringer-ingelheim.com., Saito K; Nippon Boehringer Ingelheim Co., Ltd., 2-1-1 Osaki, Shinagawa-ku, Tokyo, 141-6017, Japan., Bao H; Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT 06877, USA., Sakamoto W; Nippon Boehringer Ingelheim Co., Ltd., 2-1-1 Osaki, Shinagawa-ku, Tokyo, 141-6017, Japan.

المصدر: Respiratory investigation [Respir Investig] 2024 Jul; Vol. 62 (4), pp. 702-709. Date of Electronic Publication: 2024 May 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101581124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-5353 (Electronic) Linking ISSN: 22125345 NLM ISO Abbreviation: Respir Investig Subsets: MEDLINE

مواضيع طبية MeSH: Disease Progression* , Pulmonary Fibrosis*/epidemiology , Pulmonary Fibrosis*/therapy , Databases, Factual*, Humans ; Japan/epidemiology ; Aged ; Male ; Incidence ; Female ; Retrospective Studies ; Middle Aged ; Tacrolimus/administration & dosage ; Adrenal Cortex Hormones/administration & dosage ; Adrenal Cortex Hormones/therapeutic use ; Lung Diseases, Interstitial/epidemiology ; Lung Diseases, Interstitial/therapy ; Cohort Studies ; Aged, 80 and over

المؤلفون: Higo H; Department of Allergy and Respiratory Medicine, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Taniguchi A; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Senoo S; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Ozeki T; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Nakamura N; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Atokawa M; Department of Medical Technology, Okayama University Graduate School of Health Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Itano J; Department of Allergy and Respiratory Medicine, National Hospital Organization Minami-Okayama Medical Center, 4066, Hayashima, Hayashima-cho Tsukubo-gun, Okayama, 701-0304, Japan., Oda N; Department of Internal Medicine, Fukuyama City Hospital, 5-23-1 Zaou-cho, Fukuyama, 721-8511, Japan., Sunami R; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Shiota Y; Department of Respiratory Medicine, Okayama Rosai Hospital, 1-10-25 Chikkomidorimachi, Minami-ku, Okayama, 702-8055, Japan., Arakawa Y; Department of Respiratory Medicine, KKR Takamatsu Hospital, 4-18 Tenjinmae, Takamatsu, 760-0018, Japan., Mori Y; Department of Respiratory Medicine, KKR Takamatsu Hospital, 4-18 Tenjinmae, Takamatsu, 760-0018, Japan., Kunichika N; Department of Respiratory Medicine, Japanese Red Cross Yamaguchi Hospital, 53-1 Yahatanobaba, Yamaguchi, 753-0092, Japan., Takata I; Department of Internal Medicine, Fukuyama City Hospital, 5-23-1 Zaou-cho, Fukuyama, 721-8511, Japan., Suwaki T; Department of Respiratory Medicine, Okayama City Hospital, 3-20-1 Kitanagaseomote-cho, Kita-Ku, Okayama, 700-8557, Japan., Nakanishi N; Department of Respiratory Medicine, Ehime Prefectural Central Hospital, 83 Kasuga-cho, Matsuyama, 790-0024, Japan., Tanimoto Y; Department of Allergy and Respiratory Medicine, National Hospital Organization Minami-Okayama Medical Center, 4066, Hayashima, Hayashima-cho Tsukubo-gun, Okayama, 701-0304, Japan., Kanehiro A; Department of Respiratory Medicine, Okayama Rosai Hospital, 1-10-25 Chikkomidorimachi, Minami-ku, Okayama, 702-8055, Japan; Department of Internal Medicine, Himeji St. Mary's Hospital. 650 Nibuno, Himeji, 670-0801, Japan., Maeda Y; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Kiura K; Department of Allergy and Respiratory Medicine, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Miyahara N; Department of Allergy and Respiratory Medicine, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan; Department of Medical Technology, Okayama University Graduate School of Health Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. Electronic address: miyahara@md.okayama-u.ac.jp.

المصدر: Respiratory investigation [Respir Investig] 2024 Jul; Vol. 62 (4), pp. 695-701. Date of Electronic Publication: 2024 May 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101581124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-5353 (Electronic) Linking ISSN: 22125345 NLM ISO Abbreviation: Respir Investig Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/drug therapy , Severity of Illness Index* , Disease Progression*, Humans ; Male ; Female ; Middle Aged ; Aged ; Immunoglobulin E/blood ; Interleukin-10/blood ; Eosinophils ; Cohort Studies ; Prospective Studies ; Japan ; Forced Expiratory Volume ; East Asian People

المؤلفون: Kanaoka T; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Wakui H; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Yano Y; Non-communicable Disease Epidemiology Research Centre, Shiga University of Medical Science, Otsu, Japan., Nagasu H; Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan., Kanegae H; Genki Plaza Medical Centre for Health Care, Tokyo, Japan., Nangaku M; Division of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, Tokyo, Japan., Hirakawa Y; Division of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, Tokyo, Japan., Nakagawa N; Division of Cardiology, Nephrology, Pulmonology and Neurology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan., Wada J; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Tsuruya K; Department of Nephrology, Nara Medical University, Nara, Japan., Nakano T; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Maruyama S; Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Wada T; Department of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan., Konishi M; Department of Cardiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Nagahiro T; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Yamagata K; Department of Nephrology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan., Narita I; Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan., Yanagita M; Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Terada Y; Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kochi, Japan., Araki S; Department of Nephrology, Wakayama Medical School, Wakayama, Japan., Emoto M; Metabolism, Endocrinology, and Molecular Medicine, Nephrology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan., Okada H; Department of Nephrology, Faculty of Medicine, Saitama Medical University, Saitama, Japan., Isaka Y; Department of Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan., Suzuki Y; Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan., Yokoo T; Division of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan., Kataoka H; Faculty of Health Science and Technology, Kawasaki University of Medical Welfare, Okayama, Japan., Kanda E; Department of Medical Science, Kawasaki Medical School, Kurashiki, Japan., Kashihara N; Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan., Tamura K; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

مؤلفون مشاركون: J‐CKD‐DB investigators

المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Jul; Vol. 26 (7), pp. 2905-2914. Date of Electronic Publication: 2024 May 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

مواضيع طبية MeSH: Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use , Sodium-Glucose Transporter 2 Inhibitors*/adverse effects , Glomerular Filtration Rate*/drug effects , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/physiopathology , Renal Insufficiency, Chronic*/epidemiology , Renal Insufficiency, Chronic*/physiopathology , Renal Insufficiency, Chronic*/complications , Databases, Factual* , Diabetic Nephropathies*/epidemiology , Diabetic Nephropathies*/physiopathology , Disease Progression*, Humans ; Male ; Female ; Japan/epidemiology ; Middle Aged ; Aged ; Kidney/drug effects ; Kidney/physiopathology

المؤلفون: Takakubo T; Department of Preventive Medicine and Public Health, Tokyo Medical University, Japan., Odagiri Y; Department of Preventive Medicine and Public Health, Tokyo Medical University, Japan., Machida M; Department of Preventive Medicine and Public Health, Tokyo Medical University, Japan.; Department of Infection Prevention and Control, Tokyo Medical University Hospital, Japan., Takamiya T; Department of Preventive Medicine and Public Health, Tokyo Medical University, Japan., Fukushima N; Department of Preventive Medicine and Public Health, Tokyo Medical University, Japan., Kikuchi H; Department of Preventive Medicine and Public Health, Tokyo Medical University, Japan., Hayashi T; Department of Preventive Medicine and Public Health, Tokyo Medical University, Japan., Amagasa S; Department of Preventive Medicine and Public Health, Tokyo Medical University, Japan.; Teikyo University Graduate School of Public Health, Japan., Inoue S; Department of Preventive Medicine and Public Health, Tokyo Medical University, Japan.

المصدر: Internal medicine (Tokyo, Japan) [Intern Med] 2024 Jun 15; Vol. 63 (12), pp. 1689-1696. Date of Electronic Publication: 2024 Apr 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7235 (Electronic) Linking ISSN: 09182918 NLM ISO Abbreviation: Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/epidemiology , COVID-19*/psychology , Disease Progression*, Humans ; Male ; Female ; Middle Aged ; Longitudinal Studies ; Aged ; Chronic Disease ; Japan/epidemiology ; SARS-CoV-2 ; Pandemics ; Adult ; Surveys and Questionnaires

المؤلفون: Kato K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan. kato.koji.429@m.kyushu-u.ac.jp., Izutsu K; Department of Hematology, Toranomon Hospital, Tokyo, Japan., Nishikori M; Department of Hematology/Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Shibayama H; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan., Maeda Y; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan., Yoshimura K; Innovative Clinical Research Centre, Kanazawa University Graduate School of Medicine, Kanazawa, Japan., Tateishi U; Department of Diagnostic Radiology, Tokyo Medical and Dental University, Tokyo, Japan., Miyamoto T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan., Matsuda Y; Cancer Care Promotion Center, University of Fukui Hospital, Fukui, Japan., Ishikawa J; Department of Hematology, Osaka International Centre Institute, Osaka, Japan., Rai S; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osaka, Japan., Takahashi T; Department of Hematology, Shimane University Hospital, Shimane, Japan., Yamauchi T; Department of Hematology and Oncology, University of Fukui, Fukui, Japan., Matsumura I; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osaka, Japan., Akashi K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan., Kanakura Y; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan., Suzumiya J; Department of Hematology, Koga Community Hospital, Daikakuji 2-30-1, Yaizu, Shizuoka, 425-0088, Japan. junji8suzumiya@gmail.com.

المصدر: International journal of hematology [Int J Hematol] 2024 Jun; Vol. 119 (6), pp. 677-685. Date of Electronic Publication: 2024 Mar 22.

نوع المنشور: Journal Article; Multicenter Study; Clinical Trial, Phase II

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Follicular*/drug therapy , Lymphoma, Follicular*/diagnostic imaging , Lymphoma, Follicular*/mortality , Bendamustine Hydrochloride*/administration & dosage , Rituximab*/administration & dosage , Fluorodeoxyglucose F18*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Disease Progression* , Positron-Emission Tomography*/methods, Humans ; Middle Aged ; Aged ; Male ; Female ; Prospective Studies ; Adult ; Japan ; Recurrence ; Aged, 80 and over ; Radiopharmaceuticals/administration & dosage

المؤلفون: Urano T; Department of Geriatric Medicine, International University of Health and Welfare School of Medicine, Chiba, Japan., Kuroda T; Public Health Research Foundation, Tokyo, Japan., Shiraki M; Research Institute and Practice for Involutional Diseases, Nagano, Japan.

المصدر: Geriatrics & gerontology international [Geriatr Gerontol Int] 2024 Jun; Vol. 24 (6), pp. 523-528. Date of Electronic Publication: 2024 Apr 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Japan Geriatrics Society Country of Publication: Japan NLM ID: 101135738 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1447-0594 (Electronic) Linking ISSN: 14470594 NLM ISO Abbreviation: Geriatr Gerontol Int Subsets: MEDLINE

مواضيع طبية MeSH: Frailty*/epidemiology , Disease Progression* , Inflammation* , Comorbidity* , Frail Elderly*/statistics & numerical data, Humans ; Female ; Aged ; Cross-Sectional Studies ; Longitudinal Studies ; Risk Factors ; Japan/epidemiology ; Aged, 80 and over ; Prevalence ; Nutritional Status ; Geriatric Assessment/methods ; Biomarkers/blood ; Middle Aged

المؤلفون: Nangaku M; Division of Nephrology and Endocrinology, The University of Tokyo School of Medicine, Tokyo, 113-8655, Japan. mnangaku@m.u-tokyo.ac.jp., Herrington WG; Medical Research Council Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Goto S; Tokai University School of Medicine, Isehara, Japan., Maruyama S; Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Kashihara N; Kawasaki Medical School, Kurashiki, Japan., Ueki K; Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan., Wada J; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan., Watada H; Department of Metabolism &Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Nakashima E; Department of Diabetes and Endocrinology, Chubu Rosai Hospital, Nagoya, Japan., Lee R; Medical Research Council Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Massey D; Elderbrook Solutions GmbH On Behalf of Boehringer Ingelheim Pharma GmbH & Co.KG, Biberach, Germany., Mayne KJ; Medical Research Council Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Tomita A; Tokai University School of Medicine, Isehara, Japan., Haynes R; Medical Research Council Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Hauske SJ; Boehringer Ingelheim International GmbH, Ingelheim, Germany.; Vth Department of Medicine, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany., Kadowaki T; The University of Tokyo School of Medicine/Toranomon Hospital, Tokyo, Japan.

المصدر: Clinical and experimental nephrology [Clin Exp Nephrol] 2024 Jun; Vol. 28 (6), pp. 588-595. Date of Electronic Publication: 2024 Apr 20.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study

بيانات الدورية: Publisher: Springer Country of Publication: Japan NLM ID: 9709923 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7799 (Electronic) Linking ISSN: 13421751 NLM ISO Abbreviation: Clin Exp Nephrol Subsets: MEDLINE

مواضيع طبية MeSH: Glucosides*/therapeutic use , Glucosides*/adverse effects , Renal Insufficiency, Chronic*/drug therapy , Renal Insufficiency, Chronic*/physiopathology , Renal Insufficiency, Chronic*/diagnosis , Benzhydryl Compounds*/therapeutic use , Benzhydryl Compounds*/adverse effects , Glomerular Filtration Rate*/drug effects , Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use , Sodium-Glucose Transporter 2 Inhibitors*/adverse effects , Disease Progression* , Albuminuria*/drug therapy, Humans ; Male ; Female ; Middle Aged ; Japan/epidemiology ; Aged ; Treatment Outcome ; Kidney/physiopathology ; Kidney/drug effects ; Double-Blind Method ; Kidney Failure, Chronic/drug therapy ; Cardiovascular Diseases

المؤلفون: Ito J; Faculty of Nursing, Hyogo University, 2301, Hiraokacho-Shinzaike, Kakogawa, Hyogo, 675-0195, Japan. itojun@iuhw.ac.jp.; Division of Nephrology, School of Medicine, International University of Health and Welfare, 4-3, Kozunomori, Narita, Chiba, 286-8686, Japan. itojun@iuhw.ac.jp.; Division of Nephrology, Endocrinology and Metabolism, School of Medicine, Tokai University, 143, Shimokasuya, Isehara, Kanagawa, 259-1193, Japan. itojun@iuhw.ac.jp., Fukagawa M; Division of Nephrology, Endocrinology and Metabolism, School of Medicine, Tokai University, 143, Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.

المصدر: Clinical and experimental nephrology [Clin Exp Nephrol] 2024 Jun; Vol. 28 (6), pp. 522-530. Date of Electronic Publication: 2024 Feb 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: Japan NLM ID: 9709923 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7799 (Electronic) Linking ISSN: 13421751 NLM ISO Abbreviation: Clin Exp Nephrol Subsets: MEDLINE

مواضيع طبية MeSH: Glomerular Filtration Rate* , Renal Insufficiency, Chronic*/physiopathology , Renal Insufficiency, Chronic*/epidemiology , Renal Insufficiency, Chronic*/diagnosis, Humans ; Middle Aged ; Male ; Female ; Aged ; Japan/epidemiology ; Adult ; Risk Factors ; Proteinuria/physiopathology ; Prospective Studies ; Disease Progression ; Age Factors ; Hypertension/physiopathology ; Hypertension/epidemiology ; Smoking/epidemiology ; East Asian People

المؤلفون: Takeuchi T; T. Takeuchi, MD, PhD, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, and Saitama Medical University, Saitama., Wakasugi N; N. Wakasugi, MSc, T. Hashida, MSc, S. Uno, MSc, Astellas Pharma, Tokyo; naoko.wakasugi@astellas.com., Hashida T; N. Wakasugi, MSc, T. Hashida, MSc, S. Uno, MSc, Astellas Pharma, Tokyo., Uno S; N. Wakasugi, MSc, T. Hashida, MSc, S. Uno, MSc, Astellas Pharma, Tokyo., Makino H; H. Makino MD, PhD, Okayama University, Okayama-Shi, Japan.

المصدر: The Journal of rheumatology [J Rheumatol] 2024 Jun 01; Vol. 51 (6), pp. 613-621. Date of Electronic Publication: 2024 Jun 01.

نوع المنشور: Journal Article; Observational Study; Multicenter Study

بيانات الدورية: Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Electronic Cited Medium: Internet ISSN: 1499-2752 (Electronic) Linking ISSN: 0315162X NLM ISO Abbreviation: J Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Tacrolimus*/therapeutic use , Tacrolimus*/adverse effects , Lupus Nephritis*/drug therapy , Immunosuppressive Agents*/therapeutic use , Immunosuppressive Agents*/adverse effects, Humans ; Female ; Adult ; Male ; Japan ; Middle Aged ; Treatment Outcome ; Prospective Studies ; Young Adult ; Product Surveillance, Postmarketing ; Disease Progression ; Follow-Up Studies ; Recurrence

المؤلفون: Uemura K; Department of Urology, Yokohama City University Hospital, Kanagawa, Japan., Ito H; Department of Urology, Yokohama City University Hospital, Kanagawa, Japan., Jikuya R; Department of Urology, Yokohama City University Hospital, Kanagawa, Japan., Kondo T; Department of Urology, Yokohama City University Hospital, Kanagawa, Japan., Tatenuma T; Department of Urology, Yokohama City University Hospital, Kanagawa, Japan., Kawahara T; Department of Urology and Renal Transplantation, Yokohama City University Medical Center, Kanagawa, Japan., Ito Y; Department of Urology, Yokohama City University Hospital, Kanagawa, Japan., Komeya M; Department of Urology, Yokohama City University Hospital, Kanagawa, Japan., Muraoka K; Department of Urology, Yokohama City University Hospital, Kanagawa, Japan., Hasumi H; Department of Urology, Yokohama City University Hospital, Kanagawa, Japan., Uemura H; Department of Urology and Renal Transplantation, Yokohama City University Medical Center, Kanagawa, Japan., Makiyama K; Department of Urology, Yokohama City University Hospital, Kanagawa, Japan.

المصدر: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2024 Jun; Vol. 31 (6), pp. 678-684. Date of Electronic Publication: 2024 Feb 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/adverse effects , Carcinoma, Transitional Cell*/drug therapy , Carcinoma, Transitional Cell*/mortality , Carcinoma, Transitional Cell*/secondary , Antineoplastic Agents, Immunological*/therapeutic use , Antineoplastic Agents, Immunological*/adverse effects, Humans ; Male ; Female ; Aged ; Retrospective Studies ; Middle Aged ; Aged, 80 and over ; Japan/epidemiology ; Urinary Bladder Neoplasms/drug therapy ; Urinary Bladder Neoplasms/mortality ; Urinary Bladder Neoplasms/pathology ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal/adverse effects ; Urologic Neoplasms/drug therapy ; Urologic Neoplasms/mortality ; Urologic Neoplasms/pathology ; Disease Progression ; Survival Rate ; Immunoconjugates/therapeutic use ; Immunoconjugates/adverse effects